[1]
T. Modak, MD, DM, S. Sarkar, MD, MRCPsych, and Y. P. S. Balhara, MD, “A review of the evidence to explain pharmacological basis of injection (ab)use of buprenorphine–naloxone tablets”, J of Opioid Management, vol. 17, no. 7, pp. 141–152, Aug. 2021.